- Donate
- Understanding Rare Disease
- Living with a Rare Disease
- Community Support
- Advancing Research
- Driving Policy
- Get Involved
- Rare Disease News
- Resource Library
- About Us
- For Clinicians & Researchers
- For Patient Organizations
Last updated: June 18, 2020
Years published: 1992, 1999, 2007, 2020
NORD gratefully acknowledges Gregory Cichon and Madeline Halama, NORD Editorial Interns from the University of Notre Dame, and David E. Wesson, MD, Professor of Surgery, Baylor College of Medicine; Associate Surgeon-in-Chief, Texas Childrenโs Hospital, for assistance in the preparation of this report.
Jejunal atresia is a rare type of obstruction of the small bowel affecting newborns. Patients with this disorder are born with a complete mechanical obstruction of the proximal small intestine. The obstruction may be caused by a membrane across the lumen of the bowel (type 1) or a complete gap in the bowel (types 2 and 3). In type 3b, in addition to a gap, the jejunum folds up against one of the arteries that supply blood to distal small bowel and proximal large bowel (the ileo-colic artery and marginal artery) so that the bowel coils up in a manner that looks like an apple peel or Christmas tree. This is sometimes also called maypole bowel or pagoda bowel.
Jejunal atresia affects the passage of material through the small intestine. Symptoms in individuals with this disorder include poor feeding, vomiting bile, a swollen abdomen, and constipation.
Jejunal atresia occurs sporadically for unknown reasons in fetuses that are generally normal in all other respects. The best theory to explain what happens is that the blood flow to a segment of the bowel is cut off with the result that the affected segment disappears leaving a gap in the bowel.
There is some evidence to suggest a possible genetic cause, especially in cases of multiple jejunal atresia (type 4). This theory is based on reports of families with more than one affected child. An autosomal recessive pattern of inheritance has been proposed, but no specific genes have been found to be associated with the condition.
Recessive genetic disorders occur when an individual inherits a non-working gene from each parent. If an individual receives one working gene and one non-working gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the non-working gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier, like the parents, is 50% with each pregnancy. The chance for a child to receive working genes from both parents is 25%. The risk is the same for males and females.
Although most babies with jejunal atresia are otherwise healthy, patients with the following diagnoses are believed to be predisposed to jejunal atresia: cystic fibrosis, gastroschisis and antenatal midgut volvulus. Approximately 10% of those with jejunal atresia will also be diagnosed with cystic fibrosis. Maternal vasoconstrictive medications, maternal cigarette smoking and maternal cocaine use may contribute to developing the disease.
Jejunal atresia affects male and female newborns in equal numbers.
The atresia may be detected by ultrasound before birth but the diagnosis must be confirmed after birth. Plain x-rays of the abdomen in patients with jejunal atresia show dilated segments of bowel filled with gas and liquid. A barium swallow, which is an x-ray test after the baby drinks liquid barium, may be used to assess the upper digestive tract and confirm the obstruction. An additional finding in some patients with jejunal atresia is a smaller than normal large bowel called a microcolon beyond the point of blockage. A barium enema can confirm the bowel obstruction and unused colon.
Surgery to repair the intestinal obstruction is performed as soon as possible after delivery. A section of the intestine including the atresia will be removed and the two ends will be sewn together. Food is given by a vein but not by mouth (parenteral nutrition) for a period of time before and after surgery until proper function of the intestine is established.
Genetic counseling is recommended for patients and their families. Other treatment is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website: https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/
For information about clinical trials sponsored by private sources, contact: www.centerwatch.com
For information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/
INTERNET
Wesson DE. Intestinal Atresia. UpToDate. Updated: Mar 25, 2020. https://www.uptodate.com/contents/intestinal-atresia Accessed May 27, 2020.
Jonathan PR and Stig S. Intestinal atresia. Cancer Therapy Advisor. www.cancertherapyadvisor.com/home/decision-support-in-medicine/pediatrics/intestinal-atresia/ Accessed May 14, 2020.
Jejunal atresia. Genetic and Rare Diseases Information Center. Last updated: 10/26/2016. https://rarediseases.info.nih.gov/diseases/6799/jejunal-atresia Accessed May 14, 2020.
Jejunal Atresia. Jejunal Atresia | Nicklaus Childrenโs Hospital. June 21, 2019. https://www.nicklauschildrens.org/conditions/jejunal-atresia. Accessed May 14, 2020.
Jejunal Atresia. Online Mendelian Inheritance in Man (OMIM). 03/11/2008. https://www.omim.org/entry/243600 Accessed May 14, 2020.
NORD strives to open new assistance programs as funding allows. If we donโt have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORDโs mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View report
Your donation will help more than 30 million Americans with a rare disease navigate their diagnosis, receive financial assistance, and access the care and support they deserve. Make your tax-deductible gift today!